Processing of tetanus toxin by human antigen-presenting cells. Evidence for donor and epitope-specific processing...

Area of Science:

• Immunology
• Molecular Biology

Background:

• T cell activation is crucial for adaptive immunity.
• Antigen-presenting cells (APCs) process antigens to present epitopes to T cells.
• Individual variations in APC function can impact immune responses.

Purpose of the Study:

• To investigate differential activation of human T cell clones specific for tetanus toxin epitopes.
• To explore the role of antigen-presenting cells (APCs) from different donors in epitope presentation.
• To determine if protease activity influences the presentation of specific tetanus toxin epitopes.

Main Methods:

• Utilized human T cell clones specific for tetanus toxin epitopes 830-843 and 947-967.
• Pulsed APCs (peripheral blood lymphocytes or lymphoblastoid cell lines) from various donors with tetanus toxin.
• Assessed T cell activation and epitope presentation, including experiments with the protease inhibitor leupeptin.

Main Results:

• APCs from different donors differentially activated T cell clones specific for distinct tetanus toxin epitopes.
• While precursor T cell numbers were similar, APCs presented epitope 830-843 but not 947-967 to specific T cell clones.
• Leupeptin inhibited the activation of one T cell clone, suggesting a role for proteases in antigen processing.
• APCs could present synthetic peptides, indicating the issue was with toxin processing, not general presentation.

Conclusions:

• Tetanus toxin processing and epitope formation by APCs vary significantly between individuals.
• Differential protease activity within APCs is a likely mechanism explaining the observed variations in epitope presentation.
• These findings highlight the complexity of antigen processing and its impact on T cell-mediated immunity.